Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function
- PMID: 21979051
- PMCID: PMC3189541
- DOI: 10.1038/nature10490
Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function
Abstract
Left ventricular mass (LVM) is a highly heritable trait and an independent risk factor for all-cause mortality. So far, genome-wide association studies have not identified the genetic factors that underlie LVM variation, and the regulatory mechanisms for blood-pressure-independent cardiac hypertrophy remain poorly understood. Unbiased systems genetics approaches in the rat now provide a powerful complementary tool to genome-wide association studies, and we applied integrative genomics to dissect a highly replicated, blood-pressure-independent LVM locus on rat chromosome 3p. Here we identified endonuclease G (Endog), which previously was implicated in apoptosis but not hypertrophy, as the gene at the locus, and we found a loss-of-function mutation in Endog that is associated with increased LVM and impaired cardiac function. Inhibition of Endog in cultured cardiomyocytes resulted in an increase in cell size and hypertrophic biomarkers in the absence of pro-hypertrophic stimulation. Genome-wide network analysis unexpectedly implicated ENDOG in fundamental mitochondrial processes that are unrelated to apoptosis. We showed direct regulation of ENDOG by ERR-α and PGC1α (which are master regulators of mitochondrial and cardiac function), interaction of ENDOG with the mitochondrial genome and ENDOG-mediated regulation of mitochondrial mass. At baseline, the Endog-deleted mouse heart had depleted mitochondria, mitochondrial dysfunction and elevated levels of reactive oxygen species, which were associated with enlarged and steatotic cardiomyocytes. Our study has further established the link between mitochondrial dysfunction, reactive oxygen species and heart disease and has uncovered a role for Endog in maladaptive cardiac hypertrophy.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3189541/bin/ukmss-36289-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3189541/bin/ukmss-36289-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3189541/bin/ukmss-36289-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3189541/bin/ukmss-36289-f0004.gif)
Comment in
-
Endonuclease G: the link between mitochondria and cardiac hypertrophy?Circ Res. 2012 Feb 3;110(3):378-80. doi: 10.1161/RES.0b013e318249dcc8. Circ Res. 2012. PMID: 22302752 No abstract available.
Similar articles
-
N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators.Molecules. 2021 Nov 30;26(23):7285. doi: 10.3390/molecules26237285. Molecules. 2021. PMID: 34885867 Free PMC article.
-
Autophagy restricts mitochondrial DNA damage-induced release of ENDOG (endonuclease G) to regulate genome stability.Autophagy. 2021 Nov;17(11):3444-3460. doi: 10.1080/15548627.2021.1874209. Epub 2021 Jan 19. Autophagy. 2021. PMID: 33465003 Free PMC article.
-
Cardiomyocyte hypertrophy induced by Endonuclease G deficiency requires reactive oxygen radicals accumulation and is inhibitable by the micropeptide humanin.Redox Biol. 2018 Jun;16:146-156. doi: 10.1016/j.redox.2018.02.021. Epub 2018 Mar 1. Redox Biol. 2018. PMID: 29502044 Free PMC article.
-
Identification and validation of Loci and candidate genes linked to cardiac hypertrophy.Methods Mol Med. 2005;112:321-37. doi: 10.1385/1-59259-879-x:321. Methods Mol Med. 2005. PMID: 16010027 Review.
-
Endonuclease G is required for early embryogenesis and normal apoptosis in mice.Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15782-7. doi: 10.1073/pnas.2636393100. Epub 2003 Dec 8. Proc Natl Acad Sci U S A. 2003. PMID: 14663139 Free PMC article.
Cited by
-
Mitochondrial DNA release and sensing in innate immune responses.Hum Mol Genet. 2024 May 22;33(R1):R80-R91. doi: 10.1093/hmg/ddae031. Hum Mol Genet. 2024. PMID: 38779772 Review.
-
TET3 is a positive regulator of mitochondrial respiration in Neuro2A cells.PLoS One. 2024 Jan 16;19(1):e0294187. doi: 10.1371/journal.pone.0294187. eCollection 2024. PLoS One. 2024. PMID: 38227585 Free PMC article.
-
Systems genetics approaches for understanding complex traits with relevance for human disease.Elife. 2023 Nov 14;12:e91004. doi: 10.7554/eLife.91004. Elife. 2023. PMID: 37962168 Free PMC article. Review.
-
Single-Nucleotide Polymorphisms in Genes Maintaining the Stability of Mitochondrial DNA Affect the Occurrence, Onset, Severity and Treatment of Major Depressive Disorder.Int J Mol Sci. 2023 Sep 29;24(19):14752. doi: 10.3390/ijms241914752. Int J Mol Sci. 2023. PMID: 37834200 Free PMC article.
-
Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress.Nat Commun. 2023 Oct 4;14(1):6201. doi: 10.1038/s41467-023-41757-x. Nat Commun. 2023. PMID: 37794041 Free PMC article.
References
-
- Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997;30:1025–1028. - PubMed
-
- Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470–479. - PubMed
-
- McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart, revisited. Ann Intern Med. 2006;144:517–524. - PubMed
-
- Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med. 2007;4:436–443. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials